ID   TBCE_HUMAN              Reviewed;         527 AA.
AC   Q15813; A8K8C2; B7Z3P1;
DT   07-FEB-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   28-JAN-2026, entry version 209.
DE   RecName: Full=Tubulin-specific chaperone E;
DE   AltName: Full=Tubulin-folding cofactor E;
GN   Name=TBCE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8706133; DOI=10.1016/s0092-8674(00)80100-2;
RA   Tian G., Huang Y., Rommelaere H., Vandekerckhove J., Ampe C., Cowan N.J.;
RT   "Pathway leading to correctly folded beta-tubulin.";
RL   Cell 86:287-296(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis, and Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION.
RX   PubMed=11847227; DOI=10.1074/jbc.m200128200;
RA   Bartolini F., Bhamidipati A., Thomas S., Schwahn U., Lewis S.A.,
RA   Cowan N.J.;
RT   "Functional overlap between retinitis pigmentosa 2 protein and the tubulin-
RT   specific chaperone cofactor C.";
RL   J. Biol. Chem. 277:14629-14634(2002).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-495, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-463, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-495, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   INTERACTION WITH TBCD.
RX   PubMed=27666374; DOI=10.1016/j.ajhg.2016.08.005;
RA   Miyake N., Fukai R., Ohba C., Chihara T., Miura M., Shimizu H., Kakita A.,
RA   Imagawa E., Shiina M., Ogata K., Okuno-Yuguchi J., Fueki N., Ogiso Y.,
RA   Suzumura H., Watabe Y., Imataka G., Leong H.Y., Fattal-Valevski A.,
RA   Kramer U., Miyatake S., Kato M., Okamoto N., Sato Y., Mitsuhashi S.,
RA   Nishino I., Kaneko N., Nishiyama A., Tamura T., Mizuguchi T., Nakashima M.,
RA   Tanaka F., Saitsu H., Matsumoto N.;
RT   "Biallelic TBCD mutations cause early-onset neurodegenerative
RT   encephalopathy.";
RL   Am. J. Hum. Genet. 99:950-961(2016).
RN   [15]
RP   FUNCTION, INVOLVEMENT IN PEAMO, VARIANT PEAMO ASN-155, AND CHARACTERIZATION
RP   OF VARIANT PEAMO ASN-155.
RX   PubMed=27666369; DOI=10.1016/j.ajhg.2016.08.006;
RA   Sferra A., Baillat G., Rizza T., Barresi S., Flex E., Tasca G., D'Amico A.,
RA   Bellacchio E., Ciolfi A., Caputo V., Cecchetti S., Torella A., Zanni G.,
RA   Diodato D., Piermarini E., Niceta M., Coppola A., Tedeschi E.,
RA   Martinelli D., Dionisi-Vici C., Nigro V., Dallapiccola B., Compagnucci C.,
RA   Tartaglia M., Haase G., Bertini E.;
RT   "TBCE mutations cause early-onset progressive encephalopathy with distal
RT   spinal muscular atrophy.";
RL   Am. J. Hum. Genet. 99:974-983(2016).
RN   [16]
RP   VARIANT HRDS 52-SER--GLY-55 DEL, AND VARIANT KCS1 52-SER--GLY-55 DEL.
RX   PubMed=12389028; DOI=10.1038/ng1012;
RA   Parvari R., Hershkovitz E., Grossman N., Gorodischer R., Loeys B.,
RA   Zecic A., Mortier G., Gregory S., Sharony R., Kambouris M., Sakati N.,
RA   Meyer B.F., Al-Aqeel A.I., Al-Humaidan A.K., Al-Zanhrani F., Al-Swaid A.,
RA   Al Othman J., Diaz G.A., Weiner R., Khan K.T.S., Gordon R., Gelb B.D.;
RT   "Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and
RT   autosomal recessive Kenny-Caffey syndrome.";
RL   Nat. Genet. 32:448-452(2002).
CC   -!- FUNCTION: Tubulin-folding protein; involved in the second step of the
CC       tubulin folding pathway and in the regulation of tubulin heterodimer
CC       dissociation. Required for correct organization of microtubule
CC       cytoskeleton and mitotic splindle, and maintenance of the neuronal
CC       microtubule network. {ECO:0000269|PubMed:11847227,
CC       ECO:0000269|PubMed:27666369}.
CC   -!- SUBUNIT: Supercomplex made of cofactors A to E. Cofactors A and D
CC       function by capturing and stabilizing tubulin in a quasi-native
CC       conformation. Cofactor E binds to the cofactor D-tubulin complex;
CC       interaction with cofactor C then causes the release of tubulin
CC       polypeptides that are committed to the native state. Cofactors B and E
CC       can form a heterodimer which binds to alpha-tubulin and enhances their
CC       ability to dissociate tubulin heterodimers (By similarity). Interacts
CC       with TBCD (PubMed:27666374). {ECO:0000250|UniProtKB:Q8CIV8,
CC       ECO:0000269|PubMed:27666374}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cytoplasm, cytoskeleton
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q15813-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15813-2; Sequence=VSP_053870;
CC   -!- DISEASE: Hypoparathyroidism-retardation-dysmorphism syndrome (HRDS)
CC       [MIM:241410]: An autosomal recessive multisystem disorder characterized
CC       by hypoparathyroidism, intrauterine and postnatal growth retardation,
CC       psychomotor retardation, epilepsy, microcephaly, and facial
CC       dysmorphism. {ECO:0000269|PubMed:12389028}. Note=The disease is caused
CC       by variants affecting the gene represented in this entry.
CC   -!- DISEASE: Kenny-Caffey syndrome 1 (KCS1) [MIM:244460]: An autosomal
CC       recessive form of Kenny-Caffey syndrome, a disorder characterized by
CC       impaired skeletal development with small and dense bones, short
CC       stature, and primary hypoparathyroidism with hypocalcemia. Clinical
CC       features include cortical thickening and medullary stenosis of the
CC       tubular bones, delayed closure of fontanels, defective dentition, small
CC       eyes with hypermetropia, and frontal bossing with a triangular face.
CC       {ECO:0000269|PubMed:12389028}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Encephalopathy, progressive, with amyotrophy and optic atrophy
CC       (PEAMO) [MIM:617207]: An autosomal recessive, progressive,
CC       neurodegenerative encephalopathy with onset in infancy. Affected
CC       individuals manifest delayed psychomotor development, severe hypotonia,
CC       motor regression, spinal muscular atrophy, distal amyotrophy and
CC       weakness of all limbs, and intellectual disability of variable
CC       severity. Additional features include optic atrophy, thin corpus
CC       callosum, and cerebellar atrophy. {ECO:0000269|PubMed:27666369}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry.
CC   -!- SIMILARITY: Belongs to the TBCE family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U61232; AAB17538.1; -; mRNA.
DR   EMBL; BT007086; AAP35749.1; -; mRNA.
DR   EMBL; AK292287; BAF84976.1; -; mRNA.
DR   EMBL; AK296185; BAH12277.1; -; mRNA.
DR   EMBL; AL357556; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL672237; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; FO393422; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC008654; AAH08654.1; -; mRNA.
DR   CCDS; CCDS1605.1; -. [Q15813-1]
DR   CCDS; CCDS73052.1; -. [Q15813-2]
DR   RefSeq; NP_001072983.1; NM_001079515.3. [Q15813-1]
DR   RefSeq; NP_001274730.1; NM_001287801.2. [Q15813-2]
DR   RefSeq; NP_001274731.1; NM_001287802.1.
DR   RefSeq; NP_003184.1; NM_003193.5. [Q15813-1]
DR   PDB; 4ICU; X-ray; 2.40 A; A/B/C/D=443-527.
DR   PDB; 4ICV; X-ray; 1.45 A; A=443-527.
DR   PDBsum; 4ICU; -.
DR   PDBsum; 4ICV; -.
DR   AlphaFoldDB; Q15813; -.
DR   EMDB; EMD-2447; -.
DR   SMR; Q15813; -.
DR   BioGRID; 112768; 77.
DR   CORUM; Q15813; -.
DR   FunCoup; Q15813; 2169.
DR   IntAct; Q15813; 38.
DR   STRING; 9606.ENSP00000495202; -.
DR   GlyGen; Q15813; 2 sites, 1 N-linked glycan (1 site), 1 O-linked glycan (1 site).
DR   iPTMnet; Q15813; -.
DR   MetOSite; Q15813; -.
DR   PhosphoSitePlus; Q15813; -.
DR   BioMuta; TBCE; -.
DR   DMDM; 74762146; -.
DR   jPOST; Q15813; -.
DR   MassIVE; Q15813; -.
DR   PaxDb; 9606-ENSP00000439170; -.
DR   PeptideAtlas; Q15813; -.
DR   ProteomicsDB; 60772; -. [Q15813-1]
DR   ProteomicsDB; 6536; -.
DR   Pumba; Q15813; -.
DR   Antibodypedia; 79050; 180 antibodies from 26 providers.
DR   Antibodypedia; 81226; 3 antibodies from 1 providers.
DR   DNASU; 6905; -.
DR   Ensembl; ENST00000406207.5; ENSP00000384571.1; ENSG00000284770.3. [Q15813-1]
DR   Ensembl; ENST00000543662.4; ENSP00000439170.1; ENSG00000284770.3. [Q15813-2]
DR   Ensembl; ENST00000642610.2; ENSP00000494796.1; ENSG00000284770.3. [Q15813-1]
DR   GeneID; 6905; -.
DR   KEGG; hsa:6905; -.
DR   MANE-Select; ENST00000642610.2; ENSP00000494796.1; NM_003193.5; NP_003184.1.
DR   UCSC; uc001hwz.2; human. [Q15813-1]
DR   AGR; HGNC:11582; -.
DR   ClinPGx; PA36346; -.
DR   CTD; 6905; -.
DR   DisGeNET; 6905; -.
DR   GeneCards; TBCE; -.
DR   HGNC; HGNC:11582; TBCE.
DR   HPA; ENSG00000284770; Low tissue specificity.
DR   HPA; ENSG00000285053; Low tissue specificity.
DR   MalaCards; TBCE; -.
DR   MIM; 241410; phenotype.
DR   MIM; 244460; phenotype.
DR   MIM; 604934; gene.
DR   MIM; 617207; phenotype.
DR   Orphanet; 93324; Autosomal recessive Kenny-Caffey syndrome.
DR   Orphanet; 496756; Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome.
DR   Orphanet; 2323; Sanjad-Sakati syndrome.
DR   VEuPathDB; HostDB:ENSG00000284770; -.
DR   VEuPathDB; HostDB:ENSG00000285053; -.
DR   eggNOG; KOG3207; Eukaryota.
DR   GeneTree; ENSGT00530000063405; -.
DR   HOGENOM; CLU_017716_5_0_1; -.
DR   InParanoid; Q15813; -.
DR   OMA; SEESHMF; -.
DR   OrthoDB; 5273213at2759; -.
DR   PAN-GO; Q15813; 5 GO annotations based on evolutionary models.
DR   PhylomeDB; Q15813; -.
DR   PathwayCommons; Q15813; -.
DR   Reactome; R-HSA-389977; Post-chaperonin tubulin folding pathway.
DR   SignaLink; Q15813; -.
DR   Agora; ENSG00000284770; -.
DR   BioGRID-ORCS; 6905; 409 hits in 1146 CRISPR screens.
DR   ChiTaRS; TBCE; human.
DR   EvolutionaryTrace; Q15813; -.
DR   GeneWiki; TBCE; -.
DR   GenomeRNAi; 6905; -.
DR   Pharos; Q15813; Tbio.
DR   PRO; PR:Q15813; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q15813; protein.
DR   Bgee; ENSG00000284770; Expressed in ventricular zone and 96 other cell types or tissues.
DR   ExpressionAtlas; Q15813; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005874; C:microtubule; TAS:ProtInc.
DR   GO; GO:0043014; F:alpha-tubulin binding; IBA:GO_Central.
DR   GO; GO:0051087; F:protein-folding chaperone binding; TAS:ProtInc.
DR   GO; GO:0008344; P:adult locomotory behavior; IEA:Ensembl.
DR   GO; GO:0048589; P:developmental growth; IEA:Ensembl.
DR   GO; GO:0000226; P:microtubule cytoskeleton organization; IMP:UniProtKB.
DR   GO; GO:0007052; P:mitotic spindle organization; IMP:UniProtKB.
DR   GO; GO:0014889; P:muscle atrophy; IEA:Ensembl.
DR   GO; GO:0048936; P:peripheral nervous system neuron axonogenesis; IEA:Ensembl.
DR   GO; GO:0007023; P:post-chaperonin tubulin folding pathway; IDA:UniProtKB.
DR   GO; GO:0009791; P:post-embryonic development; IEA:Ensembl.
DR   GO; GO:0006457; P:protein folding; TAS:UniProtKB.
DR   GO; GO:0007021; P:tubulin complex assembly; IBA:GO_Central.
DR   CDD; cd17044; Ubl_TBCE; 1.
DR   FunFam; 2.30.30.190:FF:000008; Tubulin-specific chaperone E; 1.
DR   FunFam; 3.10.20.90:FF:000173; Tubulin-specific chaperone E; 1.
DR   FunFam; 3.80.10.10:FF:000268; Tubulin-specific chaperone E; 1.
DR   FunFam; 3.80.10.10:FF:000593; Tubulin-specific chaperone E; 1.
DR   Gene3D; 2.30.30.190; CAP Gly-rich-like domain; 1.
DR   Gene3D; 3.10.20.90; Phosphatidylinositol 3-kinase Catalytic Subunit, Chain A, domain 1; 1.
DR   Gene3D; 3.80.10.10; Ribonuclease Inhibitor; 2.
DR   InterPro; IPR036859; CAP-Gly_dom_sf.
DR   InterPro; IPR000938; CAP-Gly_domain.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR000626; Ubiquitin-like_dom.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR044079; Ubl_TBCE.
DR   PANTHER; PTHR18849:SF0; CILIA- AND FLAGELLA-ASSOCIATED PROTEIN 410-RELATED; 1.
DR   PANTHER; PTHR18849; LEUCINE RICH REPEAT PROTEIN; 1.
DR   Pfam; PF01302; CAP_GLY; 1.
DR   Pfam; PF14560; Ubiquitin_2; 1.
DR   SMART; SM01052; CAP_GLY; 1.
DR   SUPFAM; SSF74924; Cap-Gly domain; 1.
DR   SUPFAM; SSF52047; RNI-like; 1.
DR   SUPFAM; SSF54236; Ubiquitin-like; 1.
DR   PROSITE; PS00845; CAP_GLY_1; 1.
DR   PROSITE; PS50245; CAP_GLY_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chaperone; Cytoplasm;
KW   Cytoskeleton; Disease variant; Dwarfism; Intellectual disability;
KW   Leucine-rich repeat; Neurodegeneration; Phosphoprotein;
KW   Proteomics identification; Reference proteome; Repeat.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22223895, ECO:0007744|PubMed:22814378"
FT   CHAIN           2..527
FT                   /note="Tubulin-specific chaperone E"
FT                   /id="PRO_0000083538"
FT   DOMAIN          27..71
FT                   /note="CAP-Gly"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00045"
FT   REPEAT          154..175
FT                   /note="LRR 1"
FT   REPEAT          180..200
FT                   /note="LRR 2"
FT   REPEAT          205..226
FT                   /note="LRR 3"
FT   REPEAT          230..252
FT                   /note="LRR 4"
FT   REPEAT          253..274
FT                   /note="LRR 5"
FT   REPEAT          278..299
FT                   /note="LRR 6"
FT   REPEAT          308..329
FT                   /note="LRR 7"
FT   DOMAIN          342..384
FT                   /note="LRRCT"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22223895, ECO:0007744|PubMed:22814378"
FT   MOD_RES         463
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         495
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         220
FT                   /note="E -> EAHAQCGGSRHGLDMQKDASKFVDLCVLQKCSTSNCIISAKDHTSMR
FT                   MNVAK (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_053870"
FT   VARIANT         52..55
FT                   /note="Missing (in HRDS and KCS1)"
FT                   /evidence="ECO:0000269|PubMed:12389028"
FT                   /id="VAR_032920"
FT   VARIANT         155
FT                   /note="I -> N (in PEAMO; decreased function in the
FT                   organization of microtubule cytoskeleton and mitotic
FT                   splindle; dbSNP:rs780472451)"
FT                   /evidence="ECO:0000269|PubMed:27666369"
FT                   /id="VAR_077878"
FT   VARIANT         205
FT                   /note="V -> A (in dbSNP:rs16832611)"
FT                   /id="VAR_032921"
FT   VARIANT         333
FT                   /note="S -> T (in dbSNP:rs35579976)"
FT                   /id="VAR_032922"
FT   VARIANT         409
FT                   /note="E -> G (in dbSNP:rs16832619)"
FT                   /id="VAR_032923"
FT   CONFLICT        450
FT                   /note="I -> V (in Ref. 3; BAF84976)"
FT                   /evidence="ECO:0000305"
FT   STRAND          445..451
FT                   /evidence="ECO:0007829|PDB:4ICV"
FT   TURN            453..455
FT                   /evidence="ECO:0007829|PDB:4ICU"
FT   HELIX           457..459
FT                   /evidence="ECO:0007829|PDB:4ICV"
FT   STRAND          461..466
FT                   /evidence="ECO:0007829|PDB:4ICV"
FT   HELIX           471..482
FT                   /evidence="ECO:0007829|PDB:4ICV"
FT   HELIX           486..488
FT                   /evidence="ECO:0007829|PDB:4ICV"
FT   STRAND          490..494
FT                   /evidence="ECO:0007829|PDB:4ICV"
FT   HELIX           513..515
FT                   /evidence="ECO:0007829|PDB:4ICV"
FT   STRAND          522..526
FT                   /evidence="ECO:0007829|PDB:4ICV"
SQ   SEQUENCE   527 AA;  59346 MW;  C919052D2D463BA1 CRC64;
     MSDTLTADVI GRRVEVNGEH ATVRFAGVVP PVAGPWLGVE WDNPERGKHD GSHEGTVYFK
     CRHPTGGSFI RPNKVNFGTD FLTAIKNRYV LEDGPEEDRK EQIVTIGNKP VETIGFDSIM
     KQQSQLSKLQ EVSLRNCAVS CAGEKGGVAE ACPNIRKVDL SKNLLSSWDE VIHIADQLRH
     LEVLNVSENK LKFPSGSVLT GTLSVLKVLV LNQTGITWAE VLRCVAGCPG LEELYLESNN
     IFISERPTDV LQTVKLLDLS SNQLIDENQL YLIAHLPRLE QLILSDTGIS SLHFPDAGIG
     CKTSMFPSLK YLVVNDNQIS QWSFFNELEK LPSLRALSCL RNPLTKEDKE AETARLLIIA
     SIGQLKTLNK CEILPEERRR AELDYRKAFG NEWKQAGGHK DPEKNRLSEE FLTAHPRYQF
     LCLKYGAPED WELKTQQPLM LKNQLLTLKI KYPHQLDQKV LEKQLPGSMT IQKVKGLLSR
     LLKVPVSDLL LSYESPKKPG REIELENDLK SLQFYSVENG DCLLVRW
//
